DENVER – Recent studies have demonstrated that molecular-targeted agents, such as epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor
DENVER – The median age of patients diagnosed with advanced non–small-cell lung cancer (NSCLC) has steadily increased over the recent years and is
DENVER – Local therapy is not commonly utilized in metastatic lung cancer.
DENVER – Molecular driven therapeutic targets have resulted in a paradigm shift in thetreatment of advanced lung adenocarcinoma.
DENVER – Physicians who care for lung cancer patients recognize the importance of tobacco cessation, but often do not provide cessation assistance
DENVER – The identification of potentially targetable kinase mutations has been an exciting advancement in lung cancer treatment.